Melatonin is also a key regulator of body mass and energy expenditure through its interaction with MT2 receptors in adipose tissue
Sam West, a postdoctoral researcher at the Nuffield Department of Primary Care Health Sciences at University of Oxford, said in a news release about the studys results
Serious risks are rare but possible, including inflammation of the pancreas, gallbladder issues, or changes in mood
Tirzepatide is a dual GIP/GLP-1 receptor agonist that acts on both incretin pathways
Key Takeaways Market Scale : The GLP-1 market is projected to exceed $200 billion by 2033, making it the most significant therapeutic class for capital allocation in the next decade
Instead, the table shows the adequate intake, marked with an asterisk